+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 65Years
All Genders
ID02630121

Study of Oxymetazoline with Fluticasone Propionate for Reducing Sleep Apnea and Nasal Congestion in Adults with Mild Obstructive Sleep Apnea and Persistent Nasal Congestion

Led by University of South Florida · Updated on 2025-01-24

52

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether adding intranasal oxymetazoline for two weeks to the regular maximum doses of intranasal fluticasone propionate can reduce the number of obstructive apneas and hypopneas per hour of sleep. The study focuses on adults with mild obstructive sleep apnea and persistent nasal congestion caused by perennial allergic or non-allergic rhinitis despite treatment with nasal glucocorticosteroids. This trial is a phase 4, randomized, quadruple-blinded, placebo-controlled crossover study sponsored by the University of South Florida. Participants will receive either oxymetazoline hydrochloride or a placebo spray at bedtime along with fluticasone propionate twice daily for two weeks in each treatment phase. The study includes two treatment arms one with placebo spray plus fluticasone and the other with oxymetazoline spray plus fluticasone. Each participant undergoes both treatments in a crossover design to compare effects on sleep apnea and nasal congestion. During the study, participants will use the NOX T3 portable sleep monitor to measure the apnea-hypopnea index AHI and assess upper airway flow limitation. They will also complete questionnaires such as the Congestion Quantifier 7, Nasal Congestion Visual Analog Scale, and Rhinoconjunctivitis Quality of Life Questionnaire to evaluate nasal symptoms and quality of life. The primary outcome is the proportion of subjects with a 50% reduction in AHI after two weeks of treatment. Safety and symptom changes will be monitored throughout the study, which runs until April 2026.

CONDITIONS

Brief Title

Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

Research Team

C

Catherine R Smith

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here